Compare · CHE vs OPCH
CHE vs OPCH
Side-by-side comparison of Chemed Corp (CHE) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $6.15B, about 1.4x OPCH ($4.46B).
- Over the past year, CHE is down 25.4% and OPCH is down 13.8% - OPCH leads by 11.6 points.
- CHE has been more active in the news (6 items in the past 4 weeks vs 4 for OPCH).
- OPCH has more recent analyst coverage (13 ratings vs 6 for CHE).
- Company
- Chemed Corp
- Option Care Health Inc.
- Price
- $421.57+9.84%
- $28.41-0.49%
- Market cap
- $6.15B
- $4.46B
- 1M return
- +12.75%
- -0.28%
- 1Y return
- -25.40%
- -13.83%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 6
- 4
- Recent ratings
- 6
- 13
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest CHE
- Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Chemed Reports First-Quarter 2026 Results
- Chemed Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement
- SEC Form DEFR14A filed by Chemed Corp
- SEC Form DEF 14A filed by Chemed Corp
- Chemed To Report First Quarter 2026 Earnings April 23, Related Conference Call To Be Held On April 24
- Roto-Rooter Completes Acquisitions for Two Significant Territories
- SEC Form 4 filed by Mcnamara Kevin J
- Now Open: VITAS® Healthcare Inpatient Hospice Care at Oak Manor
Latest OPCH
- Chief Medical Officer Adewunmi Femi covered exercise/tax liability with 1,396 shares, decreasing direct ownership by 5% to 25,314 units (SEC Form 4)
- SEC Form DEFA14A filed by Option Care Health Inc.
- SEC Form DEF 14A filed by Option Care Health Inc.
- Option Care Health to Announce First Quarter 2026 Financial Results and Host Conference Call
- Option Care Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13G/A filed by Option Care Health Inc.
- Chief Human Resources Officer Bavaro Michael sold $198,000 worth of shares (6,000 units at $33.00), decreasing direct ownership by 15% to 33,249 units (SEC Form 4)
- Director Pate R Carter sold $970,620 worth of shares (30,287 units at $32.05), decreasing direct ownership by 72% to 11,623 units (SEC Form 4)
- Chief Operating Officer Whitworth Luke covered exercise/tax liability with 4,605 shares, decreasing direct ownership by 3% to 169,589 units (SEC Form 4)
- Chief Growth Officer Grashoff Christopher L. covered exercise/tax liability with 1,980 shares, decreasing direct ownership by 4% to 44,092 units (SEC Form 4)